Royal DSM, second quarter net sales fell 5%, and the company said its human nutrition sales are still operating in a low growth macro environment for some end-markets due to ongoing pressure on consumer spending.
"Market conditions in nutrition have shown some improvement with good animal nutrition performance in Q2, while human nutrition still operates in a low growth macro environment for some end-markets due to ongoing pressure on consumer spending," said Feike Sijbesma, CEO/Chairman of the DSM managing board. "In this environment, the resilience of our integrated value chain is demonstrated by robust margins, highlighting the quality of our nutrition business. In addition we are undertaking initiatives in the US to reinforce the attractiveness of our dietary supplements end-user categories."
Click here to view the entire earnings release.